CVS Health Corporation $CVS Shares Purchased by Fort Washington Investment Advisors Inc. OH

Fort Washington Investment Advisors Inc. OH raised its stake in CVS Health Corporation (NYSE:CVS) by 3.7% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 752,007 shares of the pharmacy operator’s stock after buying an additional 26,818 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in CVS Health were worth $54,009,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Caitong International Asset Management Co. Ltd increased its holdings in shares of CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares during the period. Swiss RE Ltd. acquired a new stake in CVS Health in the fourth quarter worth about $26,000. Sankala Group LLC acquired a new stake in shares of CVS Health in the 4th quarter worth approximately $28,000. Mcguire Capital Advisors Inc. bought a new position in CVS Health during the 4th quarter valued at $28,000. Finally, Ares Financial Consulting LLC bought a new position in CVS Health during the fourth quarter valued at about $29,000. Institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In other news, Director Larry Robbins sold 1,983,538 shares of the stock in a transaction that occurred on Tuesday, May 19th. The shares were sold at an average price of $94.45, for a total value of $187,345,164.10. Following the completion of the sale, the director directly owned 6,213,261 shares of the company’s stock, valued at $586,842,501.45. This represents a 24.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the transaction, the executive vice president directly owned 10,133 shares in the company, valued at $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,441,551 shares of company stock worth $323,703,977 in the last quarter. 0.85% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on CVS shares. Wall Street Zen upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CVS Health in a report on Friday, May 8th. Truist Financial raised their price objective on CVS Health from $102.00 to $108.00 and gave the stock a “buy” rating in a research note on Monday, June 1st. UBS Group lifted their target price on CVS Health from $100.00 to $115.00 and gave the stock a “buy” rating in a report on Monday, June 8th. Finally, Wells Fargo & Company boosted their target price on CVS Health from $102.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. Twenty-two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $101.28.

CVS Health Stock Performance

Shares of CVS Health stock opened at $104.38 on Friday. CVS Health Corporation has a 12 month low of $58.50 and a 12 month high of $106.15. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. The stock has a market cap of $133.18 billion, a PE ratio of 45.98, a price-to-earnings-growth ratio of 1.02 and a beta of 0.62. The business has a fifty day simple moving average of $91.81 and a 200-day simple moving average of $82.39.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, beating the consensus estimate of $2.21 by $0.36. The firm had revenue of $100.43 billion for the quarter, compared to analyst estimates of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.CVS Health’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.25 earnings per share. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, sell-side analysts anticipate that CVS Health Corporation will post 7.44 EPS for the current fiscal year.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.